Evaluation of Effects of Health Insurance Scheme on Healthcare Access among Enrollees in Ebonyi State, Nigeria
- Igwe Divine Okemefuna, Umezurike Daniel, Imakwu Innocent Icha, Nnabu Richard Chukwuka, Igboji Kingsley O., & Nwibo Sabinus O.
- DOI: 10.5281/zenodo.24185866
- ISA Journal of Medical Sciences (ISAJMS)
Access to affordable and
quality healthcare services remains a major public health concern in Ebonyi
State, Nigeria, particularly among populations facing access to healthcare
utilisation. Health insurance schemes was introduced to ease the difficulties usually
encountered among the enrollees in accessing healthcare services. In Nigeria,
out-of-pocket payments have long exceeded 70% of health expenditure, and the
National Health Insurance Authority (NHIA) Act 2022 mandated State Social
Health Insurance Agencies to expand coverage. In Ebonyi State, the Ebonyi State
Health Insurance Agency (EBSHIA) has expanded enrolment, but evidence of its
access and effect on enrolees is limited. An analytical mixed-methods design
combined a retrospective pre–post survey of 528 adult Basic Health Care
Provision Fund enrolees, recruited from 24 accredited facilities through
multistage sampling, with ten Key Informant Interviews. Paired responses were
analysed using McNemar’s test and associations using the Fisher–Freeman–Halton
exact test (α = 0.05). All twelve core indicators improved significantly after
enrolment (p < 0.001). Perceived affordability rose from 26.7% to 97.5%,
perceived adequate quality of care from 37.7% to 97.0% and effective care from
50.6% to 96.6%, while severe income-related and household-level financial
hardship fell from 86.2% to 6.4% and from 80.9% to 4.0% respectively.
Availability (83.3%) and acceptable waiting time (78.8%) remained below the
study-defined 90% benchmark, and interviews highlighted drug stock-outs,
delayed reimbursement, accessibility and staff shortages. Enrolment was
associated with substantial reported gains in access, financial protection and
perceived quality; sustaining them requires parallel investment in drug supply,
provider reimbursement and workforce capacity.
Keywords: Evaluation, Effects, Health
Insurance Scheme, Healthcare Access, Enrolees.
